Navigation Links
Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments
Date:5/7/2009

go-ahead by the Welsh Assembly in April 2009 as part of a ten-year strategy to upgrade radiotherapy provision in Wales. She said Varian equipment was selected after a rigorous tender process. "We are very excited about being able to offer our patients image-guided and RapidArc treatments," she added. "We already use Varian equipment so it also makes sense from an interface and training perspective to acquire the latest Varian technology."

With RapidArc, Varian's Clinac accelerator can target beams at a tumor while continuously rotating around the patient, delivering a precise and efficient treatment in single or multiple arcs. Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genes Linked to Spread of Breast Cancer
2. New universal breast cancer marker predicts recurrence and clinical outcome
3. Novel gene predicts local recurrence in early onset breast cancer
4. Transatlantic alliance supports breast cancer research
5. Video: Research in Womens Cancers Leading the Personalized Medicine Revolution
6. American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program
7. Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013
8. South Carolina Dermatologists Win Tennis Fans Attention With Free Skin Cancer Checks and Sun Safety Tips
9. Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona
10. Go Pink on Mothers Day to Fight Breast Cancer
11. Novel gene predicts local recurrence in early-onset breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , NEW YORK, Dec. 4 Tho... than 90 offices nationwide today, to participate ...dit, tax and advisory firm,s support for literacy ...ice day reflects our firm,s long history of volunt...gathered in the spirit of caring to brighten the h...
(Date:12/4/2009)..., , SCOTTSDALE, Ariz., Dec. 4 /PRNewswire/...elf-managed, non-traded, real estate investment tr...e agreement to acquire a three building medical of...cana, Texas, and Fort Wayne, Indiana for approxima...is subject to the satisfaction of a number of cond...
(Date:12/4/2009)..., , WASHINGTON, Dec. 4 /PRNewswire-USNew...re reform would control health care costs, Leapfro...ead through example -- delivering the best quality...vels of efficiency. Thirty-four urban, eight child...09 Leapfrog Top Hospitals, based on results from T...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)... Dental tourism is a phen...g for an alternative to the high price of dental w...ir search for lower priced dental care, people hav...oice as a dental tourist destination. , ...eing in business for more than 6 years, Mexican De...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
... 2008 Elderly patients who use antipsychotic drug...neumonia compared to non-users. This risk is highe...creases gradually thereafter. These findings are p...and behavioral problems associated with dementia a...
... Weems, Congressman Gene Green,Among High-Level Pa... in,Health Care At U.S. News & World Report Breakf...,issued by U.S. News & World Report:, EVENT TOPIC...are, will examine the "value paradigm",between adv...
...s more than 786,000 workers, CHICAGO, April 15 T...e release of its updated statistical map entitled ...sion in 2006" that details how,many employees, bro...se employees. The data clearly shows how much the,...
...ve Workflow Tools Will Help Public Health Move Be...True Community Health Surveillance ...g Systems (HMS), (http://www.hmsinc.com ), pioneer...ools that empower epidemiologists and others in,pu...
...sults of a phase IV, open label, head-to-head stud...uency subcutaneous Rebif (interferon beta-1a) prov...lar efficacy over 18 to 30 months of continued the... and Opinion journal. , The Prospective and Retro...
...ses too much on treatments and not enough on preve...run for many women, say researchers at Michigan St...ias coverage of the disease found that over a two-...t, while only 18 percent looked at prevention. , ...
Other Medicine News:Health News:Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National Press Club 2Health News:Academy of General Dentistry Releases Updated Employment Statistical Map 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 3Health News:Health Monitoring Systems Releases EpiCenter(TM) 4Health News:Study shows that high-dose, high-frequency interferon produces no additional benefit 2Health News:Study finds media coverage of breast cancer focuses too little on prevention 2
(Date:12/4/2009)...NGTON, Dec. 4 Chemistr...shed by the Pharmaceutical Research and Manufactu...drugs and vaccines in development for HIV/AIDS and...hat the 97 products in development include 23 vacc...human clinical trials or awaiting approval by the ...
(Date:12/4/2009).... 4 PharmAthene, Inc. (N...medical countermeasures against biological and che... presenting results of a study demonstrating the e...thrax model in the New Zealand White (NZW) rabbit....ion at the HHS Public Health Emergency Medical Cou...
(Date:12/4/2009)...STON, Dec. 4 OrthoAccel Technologi...hich is an acceleration device to enhance orthodon...ng Education course published by PennWell Corpora... industries, including medicine and dentistry. Th...c treatment, a summary of treatment biomechanics, ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 1State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 2State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 3Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 1Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 2Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 1Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 2
...E: LLY ) has submitted a supplemental New Drug Ap...tration (FDA) seeking approval for a new,indicatio...ent of chronic,pain, the company announced today. ...ials in chronic osteoarthritis pain of the knee an...previously completed pain studies in,diabetic peri...
...ccessfully placed in three patient...May 29 Three patients with established,cardiac is... vProtect,Luminal Shield, a self-expanding intraco...y that typically occurs when stents are deployed. ...ort for the vessel to ensure that,the target coron...
Other Medicine Technology:Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 2Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield 2
Avitene Flour
CODMAN Steerable Neuroendoscope
D185 MultiPulse Cortical Stimulator
The Wilson Plus Radiolucent Wilson Frame
Medicine Products: